Ibandronic Acid: Brands, Price & Uses in Bangladesh

Ibandronic Acid is a nitrogen-containing bisphosphonate used mainly for bone disorders in which bone breakdown (resorption) is excessive.

Established / FDA-approved uses

• Treatment of osteoporosis in postmenopausal women - to increase bone mineral density and reduce the risk of vertebral (spinal) fractures.
• Prevention of osteoporosis in postmenopausal women who are at risk of low bone mass.

Guideline-supported / commonly used indications

• Treatment and prevention of osteoporosis in men, and in glucocorticoid-induced osteoporosis, as guided by a physician (used based on clinical guidelines and local prescribing practice rather than a universal formal approval in every market).

Ibandronic Acid is not established for reversing severe bone loss on its own in every setting and is generally used together with adequate calcium and vitamin D intake, and lifestyle measures (weight-bearing exercise, smoking cessation), as advised by a physician.

Oral tablet (150 mg, once monthly)

• Take Ibandronic Acid on the same date each month, first thing in the morning, at least 60 minutes before the first food, drink (other than plain water), or any other oral medication or supplement (including calcium).
• Swallow the tablet whole with a full glass of plain water (180-240 mL) while sitting or standing upright. Do not use mineral water, coffee, tea, juice, or milk.
• Do not chew, crush, or suck the tablet, because of the potential for oropharyngeal irritation.
• Remain fully upright (sitting or standing) for at least 60 minutes after taking the dose, and do not lie down. Do not eat, drink (other than water), or take other oral medicines during this period.

Intravenous infusion (3 mg/3 mL, once every 3 months)

• Given as a slow intravenous bolus injection over 15-30 seconds by a qualified healthcare professional; oral administration precautions (fasting, upright posture) do not apply to the IV form.
• Adequate hydration is recommended before administration, and serum calcium and creatinine should be checked before each dose.

All patients should also receive adequate calcium and vitamin D supplementation as advised by their physician. If a monthly oral dose is missed, and the next scheduled dose is more than 7 days away, patients should take the missed dose the morning after they remember, then return to the original monthly schedule; if the next dose is within 7 days, the missed dose should be skipped.

Most patients tolerate Ibandronic Acid well. Reported side effects include:

Common

• Dyspepsia, nausea, abdominal pain, diarrhea or constipation
• Headache, dizziness
• Back pain, arthralgia (joint pain), myalgia (muscle pain)
• With the IV form: transient flu-like "acute phase reaction" (fever, myalgia, arthralgia) within the first few days after infusion

Less common but serious

• Esophagitis, esophageal ulcer, or esophageal erosion (oral form) - see Precautions and Warnings
• Osteonecrosis of the jaw - see Precautions and Warnings
• Atypical femoral fractures with long-term use - see Precautions and Warnings
• Severe musculoskeletal (bone, joint, or muscle) pain
• Hypersensitivity reactions, including rare anaphylaxis and severe skin reactions
• Hypocalcemia